Skip to main content
. Author manuscript; available in PMC: 2020 Dec 12.
Published in final edited form as: Antivir Ther. 2010;15(7):935–950. doi: 10.3851/IMP1667

Figure 4.

Figure 4.

Antiviral activity of cyclic phosphoramidate prodrugs of 2′-C-methylcytosine

aFrom [24] and [50]. bEffective concentration of compound required to reduce HCV replication by 50% (EC50). cIntracellular nucleoside triphosphate (NTP) after incubation at 10 μM with human hepatocytes. dSlow eluting phosphorous diastereomer by reverse phase (RP)-HPLC. eFast eluting phosphorous diastereomer by RP-HPLC.